Tolerability and efficacy of BRAF and MEK inhibitors for metastasized melanoma after intra-class switch: a multicenter, retrospective study

Salzmann M, Wald A, Stege H, Loquai C, Zimmer L, Hayani K, Heinzerling L, Gutzmer R, Enk A, Hassel JC (2022)

Publication Type: Conference contribution

Publication year: 2022

Journal

Journal der Deutschen Dermatologischen Gesellschaft Wiley-Blackwell

Publisher: WILEY

City/Town: HOBOKEN

Pages Range: 28-29

Conference Proceedings Title: JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT

Authors with CRIS profile

Lucie Heinzerling Department of Dermatology

Involved external institutions

Johannes Gutenberg-Universität Mainz (JGU) DE Germany (DE) Ludwig-Maximilians-Universität (LMU) DE Germany (DE) Ruprecht-Karls-Universität Heidelberg DE Germany (DE) Medizinische Hochschule Hannover (MHH) / Hannover Medical School DE Germany (DE) Universität Duisburg-Essen (UDE) DE Germany (DE)

How to cite

APA:

Salzmann, M., Wald, A., Stege, H., Loquai, C., Zimmer, L., Hayani, K.,... Hassel, J.C. (2022). Tolerability and efficacy of BRAF and MEK inhibitors for metastasized melanoma after intra-class switch: a multicenter, retrospective study. In JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT (pp. 28-29). HOBOKEN: WILEY.

MLA:

Salzmann, M., et al. "Tolerability and efficacy of BRAF and MEK inhibitors for metastasized melanoma after intra-class switch: a multicenter, retrospective study." Proceedings of the JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT HOBOKEN: WILEY, 2022. 28-29.

BibTeX: Download